Skip to main content
. 2016 Dec 13;9:7545–7553. doi: 10.2147/OTT.S119027

Figure 4.

Figure 4

Expression levels (expressed as −ΔCt) of miRNAs in PCa patients stratified according to risk of recurrence and progression.

Note: Black lines and whiskers indicate median values and 10–90 percentile range, respectively. *P<0.05; **P<0.01.

Abbreviations: HR, high risk; IR, intermediate risk; LR, low risk; miRNAs, microRNAs; PCa, prostate cancer.